Press "Enter" to skip to content

AbbVie’s Imbruvica fails to meet main goal in pancreatic cancer study

AbbVie Inc said on Friday its blockbuster cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer.

Also Read:   Sanofi and GSK to join forces in vaccine collaboration to fight COVID-19